Effectiveness of long‐term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand disease

BACKGROUND: Patients with symptomatic von Willebrand disease (VWD) should be offered long‐term prophylaxis (LTP) to prevent recurrent bleedings. Our objective was to evaluate the effectiveness and safety of Voncento®, a plasma‐derived FVIII/VWF concentrate (ratio 1:2.4), administrated in LTP. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Rugeri, Lucia, Harroche, Annie, Repessé, Yohan, Desprez, Dominique, Petesch, Brigitte Pan, Chamouni, Pierre, Biron, Christine, Frotscher, Birgit, Catovic, Hasan, Bracquart, Diane, Martin, Cédric, Trossaërt, Marc, Meunier, Sandrine, d'Oiron, Roseline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322399/
https://www.ncbi.nlm.nih.gov/pubmed/35438801
http://dx.doi.org/10.1111/ejh.13778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322399/
https://www.ncbi.nlm.nih.gov/pubmed/35438801
http://dx.doi.org/10.1111/ejh.13778

Ejemplares similares